e.g. mhealth
Search Results (1 to 10 of 401 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 95 Journal of Medical Internet Research
- 79 JMIR mHealth and uHealth
- 78 JMIR Research Protocols
- 57 JMIR Formative Research
- 20 JMIR Public Health and Surveillance
- 10 JMIR Diabetes
- 10 JMIR Pediatrics and Parenting
- 8 Interactive Journal of Medical Research
- 7 JMIR Medical Informatics
- 7 JMIR Serious Games
- 5 JMIR Human Factors
- 5 JMIRx Med
- 4 Iproceedings
- 4 JMIR Dermatology
- 3 JMIR Mental Health
- 2 JMIR Cancer
- 2 JMIR Medical Education
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Cardio
- 1 JMIR Infodemiology
- 1 JMIR Rehabilitation and Assistive Technologies
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Deep Phenotyping of Obesity: Electronic Health Record–Based Temporal Modeling Study
Obesity affects approximately 40% of adults and 15%‐20% of children and adolescents in the United States [1,2]. It is projected that 49% of adults will have obesity, and 24.2% have severe obesity by 2030 in the USA [3]. Obesity increases the risk of a wide spectrum of chronic diseases and causes profound economic and psychosocial burden. Obesity arises from a complex interplay of genetic [4-7], nongenetic [8,9], and epigenetic factors [10-13].
J Med Internet Res 2025;27:e70140
Download Citation: END BibTex RIS
Overweight and obesity are defined as excessive fat accumulation that can negatively affect health. People with a BMI between 25 and 30 kg/m2 are classified as overweight, while those with a BMI over 30 kg/m2 are classified as obese [1]. Overweight and obesity have become major public health issues. In 2016, more than 1.9 billion adults were overweight, with approximately 650 million experiencing obesity [2], and this number is estimated to affect half of the global population by 2030 [3].
JMIR Mhealth Uhealth 2025;13:e63313
Download Citation: END BibTex RIS
Obesity is a leading contributor to chronic disease and reduced quality of life [1,2]; yet, weight remains a sensitive and often avoided topic in clinical settings [3,4]. Despite national and global policy goals and clinical guidelines calling for earlier, more compassionate intervention [5-7], many health care professionals (HCPs) report inadequate training, lack of confidence, and fear of damaging the patient relationship when discussing weight [8-11].
JMIR Med Educ 2025;11:e65949
Download Citation: END BibTex RIS
It should be mentioned, in the 2017‐2019 wave, BMI classification adhered to the standards outlined by the International Obesity Task Force [20] (1=thinness, 2=normal weight, 3=overweight, 4=obesity). For further analysis, excess weight (ie, overweight or obesity) was determined as follows: 0=no excess weight (ie, thinness or normal weight); 1=excess weight (ie, overweight or obesity).
JMIR Public Health Surveill 2025;11:e67960
Download Citation: END BibTex RIS
Obesity, an “abnormal or excessive accumulation of fat that poses a health risk” [1], is a primary contributor to global health challenges [2]. Reports suggest its involvement in up to 80% of cases of type 2 diabetes and 43% of cardiovascular incidents [3] while significantly contributing to depression and anxiety [4].
Recent breakthroughs in bariatric medicine have elevated the role of injectable therapy, namely glucagon-like peptide-1 agonist agents such as semaglutide.
JMIR Diabetes 2025;10:e63503
Download Citation: END BibTex RIS
For example, adults with obesity, type 1 or type 2 diabetes, skin diseases, HIV, chronic pain, and cancers face pervasive stigma for their health conditions [1,4-6].
In addition to experiencing stigma from other people, negative attitudes can be internalized by adults with these health conditions, contributing to self-blame and self-devaluation (ie, self-stigma) [7,8].
JMIR Form Res 2025;9:e69548
Download Citation: END BibTex RIS
According to a report by the World Obesity Federation, more than half of the world’s population will be overweight or obese by 2035 [1]. Excess abdominal fat is a primary determinant for developing insulin resistance and other metabolic disorders [2]. Lifestyle modification is the most recommended approach for treating and preventing obesity at any stage of life [2].
JMIR Res Protoc 2025;14:e71829
Download Citation: END BibTex RIS
Obesity and mental health problems are intricately connected, with evidence suggesting a bidirectional relationship between the two [1,2]. Depression, one of the most extensively studied mental health issues, increases the risk of obesity by 58%, while obesity elevates the risk of depression by 55% [3]. Furthermore, both obesity and depression are significant risk factors for reduced work ability [4,5], and occupational burnout has been linked to these conditions [6-8].
JMIR Ment Health 2025;12:e66518
Download Citation: END BibTex RIS
Obesity remains a global health crisis, affecting 890 million adults worldwide and contributing to diseases such as type 2 diabetes, cardiovascular disease, and certain cancers [1]. In the United Kingdom, projections suggest that by 2050, the annual cost of obesity to the National Health Service (NHS) could reach £9.7 billion (US $12.1 billion), with wider societal expenses approaching £49.9 billion (US $62.4 billion) [2].
JMIR Form Res 2025;9:e72577
Download Citation: END BibTex RIS
Virtual Reality in Obesity Management: Addressing Key Limitations in Clinical Application
We are writing to express our appreciation for the recent publication in the Journal of Medical Internet Research titled “Assessing the Clinical Efficacy of a Virtual Reality Tool for the Treatment of Obesity: Randomized Controlled Trial” [1]. The authors propose an innovative approach to obesity treatment that leverages the interactivity and immersive experience of virtual reality (VR) technology through a randomized controlled trial, providing new scientific evidence for obesity management.
J Med Internet Res 2025;27:e68269
Download Citation: END BibTex RIS